Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China · Delayed Price · Currency is CNY 32.86
-0.29 (-0.87%)
At close: Jul 25, 2025, 2:57 PM CST
SHA:688139 Revenue
Qingdao Haier Biomedical Co.,Ltd had revenue of 688.99M CNY in the quarter ending March 31, 2025, with 0.30% growth. This brings the company's revenue in the last twelve months to 2.29B, up 0.21% year-over-year. In the year 2024, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.28B with 0.13% growth.
Revenue (ttm)
2.29B
Revenue Growth
+0.21%
P/S Ratio
4.52
Revenue / Employee
814.36K
Employees
2,807
Market Cap
10.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.28B | 2.94M | 0.13% |
| Dec 31, 2023 | 2.28B | -583.15M | -20.36% |
| Dec 31, 2022 | 2.86B | 738.18M | 34.72% |
| Dec 31, 2021 | 2.13B | 723.83M | 51.63% |
| Dec 31, 2020 | 1.40B | 389.51M | 38.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |